• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在英国,78430 名成年人中,每日步数和强度与痴呆症发病的相关性。

Association of Daily Step Count and Intensity With Incident Dementia in 78 430 Adults Living in the UK.

机构信息

Department of Sports Science and Clinical Biomechanics, Centre for Active and Healthy Ageing, University of Southern Denmark, Odense, Denmark.

Charles Perkins Centre, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, Camperdown, New South Wales, Australia.

出版信息

JAMA Neurol. 2022 Oct 1;79(10):1059-1063. doi: 10.1001/jamaneurol.2022.2672.

DOI:10.1001/jamaneurol.2022.2672
PMID:36066874
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9449869/
Abstract

IMPORTANCE

Step-based recommendations may be appropriate for dementia-prevention guidelines. However, the association of step count and intensity with dementia incidence is unknown.

OBJECTIVE

To examine the dose-response association between daily step count and intensity and incidence of all-cause dementia among adults in the UK.

DESIGN, SETTING, AND PARTICIPANTS: UK Biobank prospective population-based cohort study (February 2013 to December 2015) with 6.9 years of follow-up (data analysis conducted May 2022). A total of 78 430 of 103 684 eligible adults aged 40 to 79 years with valid wrist accelerometer data were included. Registry-based dementia was ascertained through October 2021.

EXPOSURES

Accelerometer-derived daily step count, incidental steps (less than 40 steps per minute), purposeful steps (40 steps per minute or more), and peak 30-minute cadence (ie, mean steps per minute recorded for the 30 highest, not necessarily consecutive, minutes in a day).

MAIN OUTCOMES AND MEASURES

Incident dementia (fatal and nonfatal), obtained through linkage with inpatient hospitalization or primary care records or recorded as the underlying or contributory cause of death in death registers. Spline Cox regressions were used to assess dose-response associations.

RESULTS

The study monitored 78 430 adults (mean [SD] age, 61.1 [7.9] years; 35 040 [44.7%] male and 43 390 [55.3%] female; 881 [1.1%] were Asian, 641 [0.8%] were Black, 427 [0.5%] were of mixed race, 75 852 [96.7%] were White, and 629 [0.8%] were of another, unspecified race) over a median (IQR) follow-up of 6.9 (6.4-7.5) years, 866 of whom developed dementia (mean [SD] age, 68.3 [5.6] years; 480 [55.4%] male and 386 [54.6%] female; 5 [0.6%] Asian, 6 [0.7%] Black, 4 [0.4%] mixed race, 821 [97.6%] White, and 6 [0.7%] other). Analyses revealed nonlinear associations between daily steps. The optimal dose (ie, exposure value at which the maximum risk reduction was observed) was 9826 steps (hazard ratio [HR], 0.49; 95% CI, 0.39-0.62) and the minimal dose (ie, exposure value at which the risk reduction was 50% of the observed maximum risk reduction) was 3826 steps (HR, 0.75; 95% CI, 0.67-0.83). The incidental cadence optimal dose was 3677 steps (HR, 0.58; 95% CI, 0.44-0.72); purposeful cadence optimal dose was 6315 steps (HR, 0.43; 95% CI, 0.32-0.58); and peak 30-minute cadence optimal dose was 112 steps per minute (HR, 0.38; 95% CI, 0.24-0.60).

CONCLUSIONS AND RELEVANCE

In this cohort study, a higher number of steps was associated with lower risk of all-cause dementia. The findings suggest that a dose of just under 10 000 steps per day may be optimally associated with a lower risk of dementia. Steps performed at higher intensity resulted in stronger associations.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d25/9449869/f70501602a37/jamaneurol-e222672-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d25/9449869/695459c83437/jamaneurol-e222672-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d25/9449869/f70501602a37/jamaneurol-e222672-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d25/9449869/695459c83437/jamaneurol-e222672-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d25/9449869/f70501602a37/jamaneurol-e222672-g002.jpg
摘要

重要性

分步推荐可能适合预防痴呆症的指南。然而,计步和强度与痴呆症发病率之间的关系尚不清楚。

目的

研究英国成年人日常计步和强度与全因痴呆症发病率之间的剂量-反应关系。

设计、地点和参与者:英国生物银行前瞻性基于人群的队列研究(2013 年 2 月至 2015 年 12 月),随访 6.9 年(数据分析于 2022 年 5 月进行)。共纳入了 78430 名符合条件的年龄在 40 至 79 岁、有有效腕部加速度计数据的成年人中的 103684 名。通过 2021 年 10 月的注册表确定痴呆症。

暴露

加速度计测量的每日计步数、偶然计步(每分钟少于 40 步)、有目的计步(每分钟 40 步或更多)和 30 分钟峰值步速(即一天中记录的最高 30 分钟内的平均每分钟步数,不一定是连续的)。

主要结果和措施

发生的痴呆症(致命和非致命),通过与住院或初级保健记录的联系或在死亡登记中记录为死亡的根本或促成原因来确定。使用样条 Cox 回归评估剂量-反应关系。

结果

该研究监测了 78430 名成年人(平均[标准差]年龄 61.1[7.9]岁;35040[44.7%]名男性和 43390[55.3%]名女性;881[1.1%]名亚洲人,641[0.8%]名黑人,427[0.5%]名混血,75852[96.7%]名白人,629[0.8%]名其他种族),中位(IQR)随访时间为 6.9(6.4-7.5)年,其中 866 人患有痴呆症(平均[标准差]年龄 68.3[5.6]岁;480[55.4%]名男性和 386[54.6%]名女性;5[0.6%]名亚洲人,6[0.7%]名黑人,4[0.4%]名混血,821[97.6%]名白人,6[0.7%]名其他种族)。分析显示每日步数之间存在非线性关联。最佳剂量(即观察到最大风险降低的暴露值)为 9826 步(危险比[HR],0.49;95%CI,0.39-0.62),最小剂量(即风险降低 50%的暴露值观察到的最大风险降低)为 3826 步(HR,0.75;95%CI,0.67-0.83)。偶然步速的最佳剂量为 3677 步(HR,0.58;95%CI,0.44-0.72);有目的步速的最佳剂量为 6315 步(HR,0.43;95%CI,0.32-0.58);30 分钟峰值步速的最佳剂量为 112 步/分钟(HR,0.38;95%CI,0.24-0.60)。

结论和相关性

在这项队列研究中,较高的步数与全因痴呆症风险降低相关。研究结果表明,每天接近 10000 步可能与痴呆症风险降低最佳相关。更高强度的步速会产生更强的关联。

相似文献

1
Association of Daily Step Count and Intensity With Incident Dementia in 78 430 Adults Living in the UK.在英国,78430 名成年人中,每日步数和强度与痴呆症发病的相关性。
JAMA Neurol. 2022 Oct 1;79(10):1059-1063. doi: 10.1001/jamaneurol.2022.2672.
2
Prospective Associations of Daily Step Counts and Intensity With Cancer and Cardiovascular Disease Incidence and Mortality and All-Cause Mortality.每日步数和强度与癌症、心血管疾病发病率和死亡率及全因死亡率的前瞻性关联。
JAMA Intern Med. 2022 Nov 1;182(11):1139-1148. doi: 10.1001/jamainternmed.2022.4000.
3
Association of Daily Step Count and Step Intensity With Mortality Among US Adults.美国成年人的日常步数和步频与死亡率的关系。
JAMA. 2020 Mar 24;323(12):1151-1160. doi: 10.1001/jama.2020.1382.
4
Sedentary Behavior and Incident Dementia Among Older Adults.老年人久坐行为与新发痴呆
JAMA. 2023 Sep 12;330(10):934-940. doi: 10.1001/jama.2023.15231.
5
Association of Step Volume and Intensity With All-Cause Mortality in Older Women.老年女性步幅和强度与全因死亡率的关联
JAMA Intern Med. 2019 Aug 1;179(8):1105-1112. doi: 10.1001/jamainternmed.2019.0899.
6
Dose-response of accelerometer-measured physical activity, step count, and cancer risk in the UK Biobank: a prospective cohort analysis.基于英国生物库的加速度计测量体力活动、步数与癌症风险的剂量-反应关系:一项前瞻性队列分析。
Lancet. 2023 Nov;402 Suppl 1:S83. doi: 10.1016/S0140-6736(23)02147-5.
7
Association of walking with incident knee osteoarthritis: a prospective cohort study using data from the UK Biobank.步行与新发膝关节骨关节炎的关联:一项使用英国生物银行数据的前瞻性队列研究。
Ann Rheum Dis. 2025 Apr;84(4):632-642. doi: 10.1016/j.ard.2025.01.019. Epub 2025 Jan 30.
8
Vigorous Intermittent Lifestyle Physical Activity and Cancer Incidence Among Nonexercising Adults: The UK Biobank Accelerometry Study.剧烈间歇性生活方式体力活动与不运动成年人的癌症发病率:英国生物银行加速度计研究。
JAMA Oncol. 2023 Sep 1;9(9):1255-1259. doi: 10.1001/jamaoncol.2023.1830.
9
Steps per Day and All-Cause Mortality in Middle-aged Adults in the Coronary Artery Risk Development in Young Adults Study.每天步数与年轻成年人冠状动脉风险发展研究中中年成年人全因死亡率的关系。
JAMA Netw Open. 2021 Sep 1;4(9):e2124516. doi: 10.1001/jamanetworkopen.2021.24516.
10
Associations Between Handgrip Strength and Dementia Risk, Cognition, and Neuroimaging Outcomes in the UK Biobank Cohort Study.英国生物库队列研究中握力与痴呆风险、认知和神经影像学结果的相关性。
JAMA Netw Open. 2022 Jun 1;5(6):e2218314. doi: 10.1001/jamanetworkopen.2022.18314.

引用本文的文献

1
A comprehensive guide to digital neurology. An update on current development on digital neurology derived from the Digital Neuro Hub project.数字神经学综合指南。源自数字神经中枢项目的数字神经学当前发展动态更新。
Neurol Sci. 2025 Sep 11. doi: 10.1007/s10072-025-08428-9.
2
Associations of daily step counts with depressive symptoms during pregnancy: Ruian birth cohort study.孕期每日步数与抑郁症状的关联:瑞安出生队列研究
BMC Public Health. 2025 Aug 19;25(1):2849. doi: 10.1186/s12889-025-24181-2.
3
Minimal Clinically Important Difference of Average Daily Steps Measured Through a Consumer Smartwatch in People With Mild-to-Moderate Parkinson Disease: Cross-Sectional Study.

本文引用的文献

1
Daily steps and all-cause mortality: a meta-analysis of 15 international cohorts.日常步数与全因死亡率:15 项国际队列研究的荟萃分析。
Lancet Public Health. 2022 Mar;7(3):e219-e228. doi: 10.1016/S2468-2667(21)00302-9.
2
Associations of Daily Steps and Step Intensity With Incident Diabetes in a Prospective Cohort Study of Older Women: The OPACH Study.一项针对老年女性的前瞻性队列研究:OPACH 研究显示,每日步数和步频强度与糖尿病发病的相关性。
Diabetes Care. 2022 Feb 1;45(2):339-347. doi: 10.2337/dc21-1202.
3
Validation of open-source step-counting algorithms for wrist-worn tri-axial accelerometers in cardiovascular patients.
通过消费型智能手表测量的轻度至中度帕金森病患者每日平均步数的最小临床重要差异:横断面研究
JMIR Mhealth Uhealth. 2025 Jul 29;13:e64213. doi: 10.2196/64213.
4
Associations Between Daily Step Counts and Sleep Parameters in Parkinson's Disease: A Scoping Review.帕金森病每日步数与睡眠参数之间的关联:一项范围综述
Sensors (Basel). 2025 Jul 17;25(14):4447. doi: 10.3390/s25144447.
5
Preoperative Cognitive Screening Predicts Postoperative Ambulatory Recovery: A Pilot Study.术前认知筛查可预测术后门诊康复情况:一项初步研究。
Clin Interv Aging. 2025 Jul 22;20:1063-1069. doi: 10.2147/CIA.S517690. eCollection 2025.
6
Device-Measured Sleep Characteristics, Daily Step Count, and Cardiometabolic Health Markers: Findings From the Prospective Physical Activity, Sitting, and Sleep (ProPASS) Consortium.设备测量的睡眠特征、每日步数及心脏代谢健康指标:来自前瞻性身体活动、久坐与睡眠(ProPASS)联盟的研究结果
Circ Cardiovasc Qual Outcomes. 2025 Jul 24;18(8):e011873. doi: 10.1161/CIRCOUTCOMES.124.011873.
7
Enhancing physical activity in older type 2 diabetic adults through remote patient monitoring: a pre-post study in Taiwan.通过远程患者监测提高老年2型糖尿病成年人的身体活动水平:台湾的一项前后对照研究。
PeerJ. 2025 Jul 9;13:e19659. doi: 10.7717/peerj.19659. eCollection 2025.
8
BRAIN-Diabetes: a randomised trial to test the feasibility of an adapted FINGER multidomain intervention in adults with type 2 diabetes living in rural border regions of Ireland.大脑-糖尿病:一项随机试验,旨在测试针对居住在爱尔兰农村边境地区的2型糖尿病成年人进行适应性FINGER多领域干预的可行性。
Eur J Ageing. 2025 Jun 24;22(1):30. doi: 10.1007/s10433-025-00862-0.
9
Effectiveness of Walking Prescription Using Mobile Health Technology on the Changes in Daily Steps in Older Adults With Cognitive Impairment: Randomized Controlled Study.使用移动健康技术的步行处方对认知障碍老年人每日步数变化的有效性:随机对照研究。
JMIR Aging. 2025 Jun 11;8:e63081. doi: 10.2196/63081.
10
Association of Alzheimer's disease concerns with amyloid burden and lifestyle behaviors in cognitively unimpaired older adults.认知未受损的老年人中阿尔茨海默病相关因素与淀粉样蛋白负荷及生活方式行为的关联。
Alzheimers Dement. 2025 Jun;21(6):e70225. doi: 10.1002/alz.70225.
腕戴三轴加速度计开源计步算法在心血管病患者中验证。
Gait Posture. 2022 Feb;92:206-211. doi: 10.1016/j.gaitpost.2021.11.035. Epub 2021 Nov 27.
4
Is Cohort Representativeness Passé? Poststratified Associations of Lifestyle Risk Factors with Mortality in the UK Biobank.队列代表性是否已经过时?英国生物库中生活方式风险因素与死亡率的后分层关联。
Epidemiology. 2021 Mar 1;32(2):179-188. doi: 10.1097/EDE.0000000000001316.
5
Association of Daily Step Count and Step Intensity With Mortality Among US Adults.美国成年人的日常步数和步频与死亡率的关系。
JAMA. 2020 Mar 24;323(12):1151-1160. doi: 10.1001/jama.2020.1382.
6
Associations of Physical Activity and β-Amyloid With Longitudinal Cognition and Neurodegeneration in Clinically Normal Older Adults.身体活动和β-淀粉样蛋白与临床正常老年人的纵向认知和神经退行性变的关联。
JAMA Neurol. 2019 Oct 1;76(10):1203-1210. doi: 10.1001/jamaneurol.2019.1879.
7
Association of Step Volume and Intensity With All-Cause Mortality in Older Women.老年女性步幅和强度与全因死亡率的关联
JAMA Intern Med. 2019 Aug 1;179(8):1105-1112. doi: 10.1001/jamainternmed.2019.0899.
8
Daily Step Counts for Measuring Physical Activity Exposure and Its Relation to Health.日常步数计数用于测量身体活动暴露及其与健康的关系。
Med Sci Sports Exerc. 2019 Jun;51(6):1206-1212. doi: 10.1249/MSS.0000000000001932.
9
Identifying dementia outcomes in UK Biobank: a validation study of primary care, hospital admissions and mortality data.在英国生物样本库中识别痴呆症结局:初级保健、住院和死亡率数据的验证研究。
Eur J Epidemiol. 2019 Jun;34(6):557-565. doi: 10.1007/s10654-019-00499-1. Epub 2019 Feb 26.
10
Using the E-Value to Assess the Potential Effect of Unmeasured Confounding in Observational Studies.使用E值评估观察性研究中未测量混杂因素的潜在影响。
JAMA. 2019 Feb 12;321(6):602-603. doi: 10.1001/jama.2018.21554.